Diabetes Care, Vol 15, Issue 9 1156-1167, Copyright © 1992 by American Diabetes Association

ARTICLES

Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus

CJ Schwartz, AJ Valente, EA Sprague, JL Kelley, AJ Cayatte and MM Rozek
Department of Pathology, Graduate School of Biomedical Sciences, University of Texas Health Science Center, San Antonio 78284-7750.

In this review, we have highlighted pivotal cellular and molecular events in the initiation and progression of atherosclerosis. Key components of lesion initiation are an enhanced focal intimal influx and accumulation of lipoproteins, including LDL in hemodynamically determined lesion-prone areas, focal monocyte-macrophage recruitment, intimal generation of ROS, and oxidative modification of lipoproteins (including LDL [Ox-LDL]). Modified lipoproteins are taken up by the non-downregulating macrophage scavenger receptor, with foam cell formation and the development of the so-called fatty streak. One transitional event in lesion progression is foam cell necrosis, likely attributable to the cytotoxicity of both intimal free radicals and Ox-LDL, with development of an extracellular metabolically inert lipid core. Another is the migration to and proliferation within the intima of medial SMCs, leading to the synthesis of plaque collagens, elastin, and proteoglycans. Mural thrombosis plays a significant role in the late-stage progression of lesions. Regression of lesions is considered a function of the dynamic balance among components of initiation, progression, plaque stabilization, and removal of plaque constituents--the so-called regression quartet. Here, we critically examine how components of diabetes mellitus might impact not only lesion development, but also lesion regression. It is concluded that some components of diabetes mellitus augment key mechanisms in lesion initiation and progression and will likely retard the processes of plaque regression. Specifically, we focus on the various influences of diabetes mellitus on lipoprotein influx and accumulation, free radical generation and Ox-LDL, monocyte-macrophage recruitment, thrombosis and impaired fibrinolysis, and the reverse cholesterol transport system. The importance of nonenzymatic protein glycosylation in modifying a number of these processes is emphasized.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Mohammadi, F. Dagenais, P. Mathieu, J. G. Kingma, D. Doyle, S. Lopez, R. Baillot, J. Perron, E. Charbonneau, E. Dumont, et al. Long-Term Impact of Diabetes and Its Comorbidities in Patients Undergoing Isolated Primary Coronary Artery Bypass Graft Surgery Circulation, September 11, 2007; 116(11_suppl): I-220 - I-225. [Abstract] [Full Text] [PDF]

				G. X. Brogan Jr, E. D. Peterson, J. Mulgund, D. L. Bhatt, E. M. Ohman, W. B. Gibler, C. V. Pollack Jr, M. E. Farkouh, and M. T. Roe Treatment Disparities in the Care of Patients With and Without Diabetes Presenting With Non-ST-Segment Elevation Acute Coronary Syndromes Diabetes Care, January 1, 2006; 29(1): 9 - 14. [Abstract] [Full Text] [PDF]

				D. Quilliot, E. Walters, J.-P. Bonte, J.-C. Fruchart, P. Duriez, and O. Ziegler Diabetes mellitus worsens antioxidant status in patients with chronic pancreatitis Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1117 - 1125. [Abstract] [Full Text] [PDF]

				G. Basta, A. M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res, September 1, 2004; 63(4): 582 - 592. [Abstract] [Full Text] [PDF]

				P L Sanchez, J L Morinigo, P Pabon, F Martin, I Piedra, I F Palacios, and C Martin-Luengo Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome Heart, March 1, 2004; 90(3): 264 - 269. [Abstract] [Full Text] [PDF]

				M. Sacco, F. Pellegrini, M. C. Roncaglioni, F. Avanzini, G. Tognoni, and A. Nicolucci Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients: Results of the Primary Prevention Project (PPP) trial Diabetes Care, December 1, 2003; 26(12): 3264 - 3272. [Abstract] [Full Text] [PDF]

				K. Kalogeropoulou, G. Mortzos, I. Migdalis, C. Velentzas, D.P. Mikhailidis, E. Georgiadis, and P. Cordopatis Carotid Atherosclerosis in Type 2 Diabetes Mellitus: Potential Role of Endothelin-1, Lipoperoxides, and Prostacyclin Angiology, May 1, 2002; 53(3): 279 - 285. [Abstract] [PDF]

				S. D. Fihn, S. V. Williams, J. Daley, and R. J. Gibbons Guidelines for the Management of Patients with Chronic Stable Angina: Treatment Ann Intern Med, October 16, 2001; 135(8_Part_1): 616 - 632. [Abstract] [Full Text] [PDF]

				A. S. Abizaid, G. S. Mintz, A. Abizaid, R. Mehran, A. J. Lansky, A. D. Pichard, L. F. Satler, H. Wu, K. M. Kent, and M. B. Leon One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms J. Am. Coll. Cardiol., September 1, 1999; 34(3): 707 - 715. [Abstract] [Full Text] [PDF]

				S. P. Marso, S. G. Ellis, E. M. Tuzcu, P. L. Whitlow, I. Franco, R. E. Raymond, and E. J. Topol The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1269 - 1277. [Abstract] [Full Text] [PDF]

				Y.-Q. Chen, M. Su, R. R. Walia, Q. Hao, J. W. Covington, and D. E. Vaughan Sp1 Sites Mediate Activation of the Plasminogen Activator Inhibitor-1 Promoter by Glucose in Vascular Smooth Muscle Cells J. Biol. Chem., April 3, 1998; 273(14): 8225 - 8231. [Abstract] [Full Text] [PDF]

				S. Agewall and B. Fagerberg Risk Factors That Predict Development of Microalbuminuria in Treated Hypertensive Men Angiology, October 1, 1996; 47(10): 963 - 972. [Abstract] [PDF]

				O. Samuelsson, K. Pennert, O. Andersson, G. Berglund, T. Hedner, B. Persson, H. Wedel, and L. Wilhelmsen Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study BMJ, September 14, 1996; 313(7058): 660 - 663. [Abstract] [Full Text]

				Z.-S. Huang, C.-H. Wang, P.-K. Yip, C.-Y. Yang, and T.-K. Lee In Hypercholesterolemia, Lower Peripheral Monocyte Count Is Unique Among the Major Predictors of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 256 - 261. [Abstract] [Full Text]

				J. R. Sowers and M. Epstein Diabetes Mellitus and Associated Hypertension, Vascular Disease, and Nephropathy : An Update Hypertension, December 1, 1995; 26(6): 869 - 879. [Abstract] [Full Text]

				H. C. McGill Jr, C. A. McMahan, G. T. Malcom, M. C. Oalmann, and J. P. Strong Relation of Glycohemoglobin and Adiposity to Atherosclerosis in Youth Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 431 - 440. [Abstract] [Full Text]